Recro Pharma Inc. (REPH)
NASDAQ: REPH
· Real-Time Price · USD
2.09
-0.01 (-0.48%)
At close: Mar 22, 2022, 5:00 AM
Recro Pharma Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -63.3 | -11.45 | -14.21 | -9.46 | -3.3 | -4.31 | -4.52 | -3.84 | -3.78 | -7.6 | 18.26 | -3.07 |
PEG Ratio | 0.77 | -0.48 | 0.43 | 0.14 | -0.1 | n/a | 0.32 | -0.14 | -0.06 | 0.02 | -0.16 | 0.06 |
PS Ratio | 7.18 | 8.92 | 8.37 | 8.23 | 4.98 | 5.49 | 5.11 | 5.56 | 3.94 | 5.81 | 5.00 | 4.94 |
PB Ratio | 3.39 | 3.61 | n/a | 3.17 | 2.02 | 3.36 | 3.17 | 3.01 | 2.09 | 2.38 | 3.41 | -9.51 |
P/FCF Ratio | -87.64 | n/a | n/a | -28.45 | -163.03 | -64.51 | 318.84 | -12.03 | 45.82 | 34.99 | 41.18 | -52.98 |
P/OCF Ratio | -1.36K | n/a | n/a | -62.12 | 60.66 | 250.39 | 60.08 | -14.58 | 19.79 | 28.78 | 31.92 | -932.23 |
OCF/S Ratio | -0.01 | n/a | n/a | -0.13 | 0.08 | 0.02 | 0.09 | -0.38 | 0.20 | 0.20 | 0.16 | -0.01 |
Debt / Equity Ratio | 0.72 | 0.26 | n/a | 0.24 | 0.22 | 0.22 | 0.21 | 2.67 | 2.46 | 2.30 | 3.40 | -10.49 |
Quick Ratio | 0.86 | 1.73 | n/a | 1.86 | 1.99 | 2.83 | 3.30 | 3.66 | 2.74 | 3.63 | 12.81 | 4.11 |
Current Ratio | 1.07 | 2.30 | n/a | 2.45 | 2.44 | 3.49 | 3.93 | 4.52 | 3.24 | 4.36 | 14.29 | 5.17 |
Asset Turnover | 0.18 | 0.16 | n/a | 0.14 | 0.15 | 0.14 | 0.15 | 0.14 | 0.14 | 0.12 | 0.15 | 0.19 |
Interest Coverage | -2.28 | 0.60 | 0.42 | 3.15 | 1.33 | 0.06 | 0.09 | -0.25 | 0.32 | 0.09 | 0.47 | -0.73 |
Return on Equity | -0.01 | -0.08 | n/a | -0.08 | -0.15 | -0.2 | -0.18 | -0.2 | -0.14 | -0.08 | 0.05 | 0.77 |
Return on Assets | -0.01 | -0.03 | n/a | -0.03 | -0.06 | -0.05 | -0.04 | -0.05 | -0.04 | -0.02 | 0.01 | -0.08 |
Return on Invested Capital | 0.04 | -0.01 | n/a | -0.05 | -0.26 | n/a | n/a | -0.01 | 0.02 | n/a | 0.02 | -0.03 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.28 | 0.16 | 0.21 | 0.10 | 0.28 | 0.26 | 0.25 | 0.24 | 0.30 | 0.28 | 0.32 | 0.15 |
Net Profit Margin | -0.03 | -0.19 | -0.15 | -0.22 | -0.38 | -0.32 | -0.28 | -0.36 | -0.26 | -0.19 | 0.07 | -0.4 |
Pretax Profit Margin | -0.03 | -0.19 | -0.15 | -0.21 | -0.33 | -0.15 | -0.13 | -0.2 | -0.11 | -0.19 | 0.07 | -0.4 |
Operating Profit Margin | 0.21 | -0.07 | -0.04 | -0.31 | -1.34 | 0.01 | 0.01 | -0.04 | 0.05 | 0.02 | 0.10 | -0.17 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.27 | -0.07 | -0.04 | -0.12 | -1.59 | 0.11 | 0.10 | -0.04 | 0.14 | 0.12 | 0.38 | -0.05 |